Jump Financial, LLC Esperion Therapeutics, Inc. Transaction History

Jump Financial, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$2.02 - $3.02 $26,136 - $39,075	12,939 Added 50.11%	38,762 $103,000
Q4 2023 Oct 21, 2024	BUY	$0.73 - $3.08 $18,850 - $79,534	25,823 New	25,823 $77,000
Q4 2023 Feb 07, 2024	BUY	$0.73 - $3.08 $18,850 - $79,534	25,823 New	25,823 $77,000
Q3 2022 Nov 07, 2022	SELL	$5.45 - $8.13 $29,430 - $43,902	-5,400 Reduced 8.71%	56,600 $379,000
Q2 2022 Aug 09, 2022	BUY	$4.77 - $6.67 $35,298 - $49,358	7,400 Added 13.55%	62,000 $395,000
Q1 2022 May 12, 2022	BUY	$3.34 - $5.56 $182,364 - $303,576	54,600 New	54,600 $253,000
Q4 2021 Feb 10, 2022	SELL	$4.81 - $11.92 $129,869 - $321,840	-27,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$11.34 - $21.37 $306,180 - $576,990	27,000 New	27,000 $326,000

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $168M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.